Y-mAbs Therapeutics Inc. logo

Y-mAbs Therapeutics Inc. (YMAB)

Delisted
16 Sep 2025
NASDAQ (NGS) NASDAQ (NGS)
$
8. 61
+0.02
+0.2328%
$
391.22M Market Cap
- P/E Ratio
- Div Yield
760,675 Volume
-0.46 Eps
$ 8.59
Previous Close
Day Range
8.61 8.61
Year Range
3.55 16.11
Want to track YMAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
6 Nov 2025
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
7 Aug 2025
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
5 May 2025
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
26 Feb 2025
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
11 Nov 2024
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
8 Aug 2024
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
7 May 2024
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
29 Feb 2024
-
-
Y-mAbs Therapeutics Inc. logo
YMAB Y-mAbs Therapeutics Inc.
6 Nov 2023
-
-